BCL9L and breast cancer: This confirms that Wnt/β-catenin signalling has a tumourigenic effect on BC and further strengthens the hypothesis that BCL9L protein is able to induce malignancy of Cal29 cells through Wnt/β-catenin signalling because both BCL9L protein depletion and iCRT3 inhibit the malignant behaviour of Cal29 cells.